Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Publications found: 742
Sort by:

United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers

US$ 1,995.00

... which is far better than the traditional technique to treat cancer. “United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers” is a report published by Renub Research. In this report ...

July 2019 -

Asia Pacific Autoimmune Disease Therapeutics Market (2019-2025)

US$ 1,500.00

The Asia Pacific Autoimmune Disease Therapeutics Market would witness market growth of 5.72% CAGR during the forecast period (2019–2025). Autoimmune diseases can be understood as disorders in which the immune ...

July 2019 108 pages

Europe Autoimmune Disease Therapeutics Market (2019-2025)

US$ 1,500.00

The Europe Autoimmune Disease Therapeutics Market would witness market growth of 3.94% CAGR during the forecast period (2019–2025). Epigenetic ...

July 2019 106 pages

Global Autoimmune Disease Therapeutics Market (2019-2025)

US$ 3,600.00

The Global Autoimmune Disease Therapeutics Market size is expected to reach $149.4 billion by 2025, rising at a market growth of 4.34% CAGR during the forecast period. The autoimmune disease therapeutics market is anticipated to experience significant market growth ...

July 2019 269 pages

Latin America, Middle East & Africa Autoimmune Disease Therapeutics Market (2019-2025)

US$ 1,500.00

The Latin America, Middle East and Africa Autoimmune Disease Therapeutics Market would witness market ...

July 2019 106 pages

North America Autoimmune Disease Therapeutics Market (2019-2025)

US$ 1,500.00

The North America Autoimmune Disease Therapeutics Market would witness market growth of 3.72% CAGR during the forecast period (2019–2025). Approximately 50 million Americans suffer from autoimmune diseases, according ...

July 2019 94 pages

Global Cell and Gene Therapy Market: Focus on Products, Applications, Regions and Competitive Landscape – Analysis and Forecast, 2019-2025

US$ 2,500.00

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. Key Questions Answered in this Report:What a...

July 2019 243 pages

Global Cell therapy Technologies Market Size study, by Product (Consumables, Equipment, Systems & Software), Process (Cell Processing, Cell prevention, Distribution, and Handling), Cell Type (Human Cells, Animal Cells), End User (Life Science Research Companies, Research Institutes) and Regional Forecasts 2019-2026

US$ 3,750.00

... the growth of Cell Therapy Market over the forecast period of 2019-2026. The regional analysis of global Cell therapy Technologies is considered for ... Forecast period – 2019 to 2026 Target Audience of the Global Cell therapy Technologies in Market Study: Key Consulting Companies & Advisors Large, medium-sized ...

July 2019 200 pages

Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2026

US$ 5,370.00

... for the market. The global natural killer cell therapeutics market is segmented based on therapeutics, application, end user, and region. Depending on therapeutics, the natural killer cells therapeutics market is classified into NK cell therapies and NK cell directed ...

July 2019 217 pages

Global Phage Therapy Market: Size, Trends & Forecasts (2019 Edition)

US$ 800.00

... Global Phage Therapy Market: Size, Trends & Forecasts (2019 Edition)” presents an analysis of the global phage market in terms of value. This is followed by a market opportunity analysis of phage therapy ... such as pneumonia and bacteremia. The global phage therapy market can be segmented on the basis of ...

June 2019 56 pages

Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs by (CLL, ALL, CML, AML)), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024

US$ 5,650.00

... major activities in estimating the current size of the leukemia therapeutics market. Exhaustive secondary research was done to collect information on the ... The demand side of this market is characterized by the significant use of immunotherapies and targeted drugs for leukemia treatment owing to the increasing ...

May 2019 126 pages

Global Longevity and Anti-senescence Therapy Market

US$ 5,500.00

... potential entrants in the global longevity and anti-senescence therapy market. REPORT INCLUDES: 71 data tables and 40 additional tables An overview of the global longevity and anti-senescence therapy market Analyses of global market trends, with data from ...

May 2019 102 pages

Global Central Nervous System Therapeutic Market : Analysis By Disease (Cancer, Neurovascular, Degenerative disorder, Mental Health, Trauma and Infection), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Region (North America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, China, Japan, India, Brazil)

US$ 2,200.00

... analysis of Global Central nervous System Therapeutic Market. The report analyzes the Central Nervous System Therapeutic Market By Disease (Cancer, Neurovascular, Degenerative disorder, Mental Health, Trauma, Infection). The Central Nervous System Therapeutic Market ...

March 2019 214 pages

Global Phototherapy Devices Market: Focus on Applications, Configuration, Products, End-users, and 15 Countries Data - Analysis and Forecast, 2018-2028

US$ 2,500.00

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. The phototherapy devices market is an emergi...

March 2019 182 pages

Global Allergy Immunotherapy (AIT) Market: Industry Analysis & Outlook (2019-2023)

US$ 800.00

Allergy Immunotherapy (AIT), also known as desensitization, is a treatment option for environmental allergies and asthma. It is aimed to induce ... and increasing prevalence of allergy. However, in terms of patients volume receiving AIT, the U.S. dominates the market. The global AIT market is highly consolidated ...

March 2019 65 pages

Global Radiotherapy Market Size study, by Type (External beam radiation therapy, Internal radiation therapy and Systemic radiation therapy), Application (skin & lip cancer, breast Cancer, head & neck cancer, prostate cancer, cervical cancer, spine cancer, lung cancer and others) End-user (hospitals, cancer research institutes and ambulatory & radiotherapy centers) and Regional Forecasts 2018-2025

US$ 3,750.00

... type, application and end-user. Type segment of global radiotherapy market is classified into external beam radiation therapy, internal ... to 2025 Target Audience of the Global Radiotherapy Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists ...

February 2019 200 pages

Global Cryotherapy Unit Market Outlook 2018-2023

US$ 3,000.00

... Global Cryotherapy Unit Market Outlook 2018-2023' offers detailed coverage of cryotherapy unit industry and presents main market trends. The market research gives historical and forecast market ... inputs from key industry participants. The global cryotherapy unit market has been segmented into five major regions ...

January 2019 119 pages

Global Renal Replacement Therapy Market Research and Forecast, 2018-2023

US$ 3,600.00

... and segments: 1. Global Renal Replacement Therapy Market Research and Analysis by Therapy type 2. Global Renal Replacement Therapy Market Research and Analysis by Route 3. Global Renal Replacement Therapy Market Research and Analysis by End-user 4. Global Renal Replacement Therapy Market Research and Analysis ...

January 2019 -

Global Autoimmune Disease Therapeutics Industry Market Research Report

US$ 2,960.00

The Autoimmune Disease Therapeutics market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Bas...

January 2019 118 pages

Hormone Replacement Therapy (HRT): Market Research Report

US$ 5,600.00

This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Thousand. The report provides separate comprehensive analytics for the US, ... 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

January 2019 181 pages

Sepsis Therapeutics: Market Research Report

US$ 5,600.00

This report analyzes the worldwide markets for Sepsis Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, ... forecasts are provided for the period 2018 through 2024. Market data and analytics are derived from primary and secondary ...

December 2018 79 pages

Global CNS Therapeutics Market Size study, by Type (Neurodegenerative, Mood Disorders, Schizophrenia, Autism, Depression), by Application (Hospital Use, Clinic Use, Household, Others) and Regional Forecasts 2018-2025

US$ 3,750.00

... – 2018 to 2025 Target Audience of the Global CNS Therapeutics Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value ...

December 2018 200 pages

Global Oncolytic Virus Therapy Market Size study, by Type (Oncolytic Wild Type Viruses, Genetically Engineered Oncolytic Viruses), by Application (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer) and Regional Forecasts 2018-2025

US$ 3,750.00

... of global oncolytic virus therapy market are lack of awareness among users and new class of anticancer immunotherapy. Oncolytic virus therapy is a virus that ... period – 2018 to 2025 Target Audience of the Global Oncolytic Virus Therapy Market in Market Study: Key Consulting Companies & Advisors Large, medium ...

December 2018 200 pages

Global Oncolytic Virus Therapy Market Research and Forecast, 2018-2023

US$ 3,600.00

... pembrolizumab (Keytruda). RESEARCH METHODOLOGY The market study of global oncolytic virus therapy market is incorporated by extensive primary ... global oncolytic virus therapy market. Insights about market determinants which are stimulating the global oncolytic virus therapy market. Detailed and extensive market ...

December 2018 -

Global Non-Invasive Prenatal Testing (NIPT) Market: Focus on Tests, Methods, Platforms, Applications, 26 Countries’ Analysis, Patent Landscape, and Competitive Landscape - Analysis and Forecast, 2018-2028

US$ 2,500.00

Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request. The life science industry is focused on the...

October 2018 406 pages

Diacylglycerol O Acyltransferase 1 (Diglyceride Acyltransferase 1 or ACAT Related Gene Product 1 or Acyl CoA Retinol O Fatty Acyltransferase or DGAT1 or EC 2.3.1.76 or EC 2.3.1.20) - Pipeline Review, H2 2018

US$ 3,500.00

... by Companies/Universities. It also reviews key players involved in Diacylglycerol O Acyltransferase 1 (Diglyceride Acyltransferase 1 or ACAT Related Gene Product 1 or Acyl CoA Retinol O Fatty Acyltransferase or DGAT1 or EC 2.3.1.76 or EC 2.3.1.20) targeted therapeutics development with respective active and ...

October 2018 29 pages

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H2 2018

US$ 3,500.00

... Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

October 2018 64 pages

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Pipeline Review, H2 2018

US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) development landscape Develop and design in-licensing and ...

October 2018 55 pages

Radiation Injury - Pipeline Review, H2 2018

US$ 2,000.00

... releases. The Radiation Injury (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

October 2018 50 pages

Global Allergy Immunotherapy Market (2018-2022 Edition)

US$ 800.00

... titled “Global Allergy Immunotherapy Market (2018-2022 Edition)”, provides an in-depth analysis of the global allergy immunotherapy market by value, by methods of administration, by region, etc. The report provides a regional analysis of the allergy immunotherapy market, including ...

September 2018 70 pages

Global Proton Therapy Market & Forecast (12 Countries Market Data), Patients Treated at Proton Therapy Centers, Reimbursement Policies

US$ 1,990.00

... . It also explains complete structure of reimbursement policies. Global Proton Therapy Market & Forecast (12 Countries Market Data), Patients Treated at Proton Therapy Centers, Reimbursement Policies is the 15th report published by Renub Research on Proton Therapy Market. This 238 page report with ...

September 2018 -

Hemophilia B - Pipeline Review, H2 2018

US$ 2,000.00

... releases. The Hemophilia B (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hemophilia B and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

September 2018 135 pages

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2018

US$ 3,500.00

... Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

September 2018 60 pages

Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2018

US$ 2,000.00

... . The Alpha-Antitrypsin Deficiency (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Alpha-Antitrypsin Deficiency and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

August 2018 83 pages

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2018

US$ 3,500.00

... Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

August 2018 70 pages

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H2 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) development landscape Develop and ...

August 2018 59 pages

Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Pipeline Review, H2 2018

US$ 3,500.00

... Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

August 2018 35 pages

E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H2 2018

US$ 3,500.00

... type. It also reviews key players involved in E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) targeted therapeutics development with respective active and ...

August 2018 81 pages

Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) - Pipeline Review, H2 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) development landscape Develop and ...

August 2018 74 pages

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1 Related Kinase or HP86 or Protein Kinase Minibrain Homolog or DYRK1A or EC 2.7.12.1) - Pipeline Review, H2 2018

US$ 3,500.00

... reviews key players involved in Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1 Related Kinase or HP86 or Protein Kinase Minibrain Homolog or DYRK1A or EC 2.7.12.1) targeted therapeutics development with respective ...

August 2018 48 pages

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis

US$ 1,800.00

... of cancer even in the advanced stages. According to report on “Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis”, T-cell Immunotherapy is a rapidly expanding field of oncology. This therapy is intended ...

August 2018 110 pages

Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H2 2018

US$ 3,500.00

... Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

August 2018 64 pages

Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H2 2018

US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) development landscape Develop ...

August 2018 73 pages

Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Pipeline Review, H2 2018

US$ 3,500.00

... Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

August 2018 75 pages

Asian Cryotherapy Units Market Size study, Regional Forecasts 2018-2025

US$ 3,150.00

Asian Cryotherapy Units Market to reach USD XXX billion by 2025. Asian Cryotherapy Units Market valued approximately USD XXX billion in 2016 is ... Target Audience of the Asian Cryotherapy Units Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture ...

August 2018 120 pages

PEGylated Protein Therapeutics Market by Product Type (Colony Stimulating Factor, Interferon, Erythropoietin (EPO), Recombinant Factor VIII, Monoclonal Antibody, Enzyme, and Others) By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others) By Sales Channel (Hospital Pharmacy, Online Provider, and Retail Pharmacy) - Global Opportunity Analysis and Industry Forecast, 2018-2025

US$ 5,370.00

... drug stability, which boost its demand in the market. The global PEGylated protein therapeutics market was valued at $10,388 million in 2017, and ... 6.9% from 2018 to 2025. The factors that propel the PEGylated protein therapeutics market growth include high prevalence of chronic diseases, such as cancer ...

August 2018 166 pages

Stroke Diagnostics and Therapeutics - Global Market Outlook (2017-2026)

US$ 4,150.00

... the growth in the stroke diagnostics and therapeutics market in Asia. Some of the key players diagnostics and therapeutics market include are Siemens ... and Daiichi Sankyo. Types Covered: Diagnostics Therapeutics Applications Covered: Haemorrhagic Stroke Ischemic Stroke Regions Covered: North America US Canada ...

July 2018 188 pages

Barth Syndrome - Pipeline Review, H2 2018

US$ 2,000.00

... releases. The Barth Syndrome (Other Diseases) pipeline guide also reviews of key players involved in therapeutic development for Barth Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

July 2018 42 pages

Filters

Search

Publishers

9
86
19
2
53
6
6
2
16
34
2
1
20
1
2
24
16
2
2
2
12
1
1
1
126
1
1
2
10
8
1
20
7
2
2
2
2
4
1
2
3
1
4
23
6
5
18
6
19
19
9
19
27
19
17
17
17
2

Regions

1
2
3
1
1
1
5
6
2
1
2
2
3
3
1
2
20
3
8
2
673

Price

Date

Pages

Offers

1